Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


CABB acquires Kemfine

German specialty chemical firm CABB (Sulzbach am Taunus) has acquired Finnish specialty chemical company KemFine (Helsinki). Both firms are engaged in contract manufacturing of agrochemicals and intermediates. CABB is a portfolio company of European private equity firm Bridgepoint Capital Group while KemFine belonged to private equity firm 3i Private Equity. “KemFine is an outstanding company with more than ten years of solid growth and, by combining CABB and KemFine, Bridgepoint will create a business with highly complementary customers, chemistries and technologies with the prospect of becoming an undisputed leader in its field,” says director at investment bank The Valence Group, Anton Ticktin. The bank advised CABB on the acquisition. Terms were not disclosed.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts